Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 69 entries
Sorted by: Best Match Show Resources per page
Benign and malignant hepatocellular lesions in patients with vascular liver disease.

Clinical liver disease

Vilgrain V, Rautou PE, Paradis V, Ronot M.
PMID: 30992904
Clin Liver Dis (Hoboken). 2014 Jun 25;3(6):122-125. doi: 10.1002/cld.338. eCollection 2014 Jun.

No abstract available.

Cite
Vilgrain V, Rautou PE, Paradis V, et al. Benign and malignant hepatocellular lesions in patients with vascular liver disease. Clin Liver Dis (Hoboken). 2014;3(6):122-125doi: 10.1002/cld.338.
Vilgrain, V., Rautou, P. E., Paradis, V., & Ronot, M. (2014). Benign and malignant hepatocellular lesions in patients with vascular liver disease. Clinical liver disease, 3(6), 122-125. https://doi.org/10.1002/cld.338
Vilgrain, Valérie, et al. "Benign and malignant hepatocellular lesions in patients with vascular liver disease." Clinical liver disease vol. 3,6 (2014): 122-125. doi: https://doi.org/10.1002/cld.338
Vilgrain V, Rautou PE, Paradis V, Ronot M. Benign and malignant hepatocellular lesions in patients with vascular liver disease. Clin Liver Dis (Hoboken). 2014 Jun 25;3(6):122-125. doi: 10.1002/cld.338. eCollection 2014 Jun. PMID: 30992904; PMCID: PMC6448717.
Copy Download .nbib Format: NLM
Segmental Arterial Mediolysis.

Radiology

Borde P, Vilgrain V.
PMID: 34783591
Radiology. 2021 Nov 16;211869. doi: 10.1148/radiol.2021211869. Epub 2021 Nov 16.

Cite
Borde P, Vilgrain V. Segmental Arterial Mediolysis. Radiology. 2021;211869doi: 10.1148/radiol.2021211869.
Borde, P., & Vilgrain, V. (2021). Segmental Arterial Mediolysis. Radiology, 211869. https://doi.org/10.1148/radiol.2021211869
Borde, Paul, and Vilgrain, Valérie. "Segmental Arterial Mediolysis." Radiology vol. (2021): 211869. doi: https://doi.org/10.1148/radiol.2021211869
Borde P, Vilgrain V. Segmental Arterial Mediolysis. Radiology. 2021 Nov 16;211869. doi: 10.1148/radiol.2021211869. Epub 2021 Nov 16. PMID: 34783591.
Copy Download .nbib Format: NLM
Soluble VE-cadherin: not just a marker of endothelial permeability.

The European respiratory journal

Harki O, Faury G, Vilgrain I, Pépin JL, Briançon-Marjollet A.
PMID: 34711535
Eur Respir J. 2021 Oct 28; doi: 10.1183/13993003.02629-2021. Epub 2021 Oct 28.

No abstract available.

Cite
Harki O, Faury G, Vilgrain I, et al. Soluble VE-cadherin: not just a marker of endothelial permeability. Eur Respir J. 2021;doi: 10.1183/13993003.02629-2021.
Harki, O., Faury, G., Vilgrain, I., Pépin, J. L., & Briançon-Marjollet, A. (2021). Soluble VE-cadherin: not just a marker of endothelial permeability. The European respiratory journal, . https://doi.org/10.1183/13993003.02629-2021
Harki, Olfa, et al. "Soluble VE-cadherin: not just a marker of endothelial permeability." The European respiratory journal vol. (2021). doi: https://doi.org/10.1183/13993003.02629-2021
Harki O, Faury G, Vilgrain I, Pépin JL, Briançon-Marjollet A. Soluble VE-cadherin: not just a marker of endothelial permeability. Eur Respir J. 2021 Oct 28; doi: 10.1183/13993003.02629-2021. Epub 2021 Oct 28. PMID: 34711535.
Copy Download .nbib Format: NLM
Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies.

Journal of hepatology

Beaufrère A, Caruso S, Calderaro J, Poté N, Bijot JC, Couchy G, Cauchy F, Vilgrain V, Zucman-Rossi J, Paradis V.
PMID: 34624411
J Hepatol. 2022 Feb;76(2):343-352. doi: 10.1016/j.jhep.2021.09.034. Epub 2021 Oct 06.

BACKGROUND & AIMS: Microvascular invasion (MVI), a major risk factor for tumor recurrence after surgery in hepatocellular carcinoma (HCC), is only detectable by microscopic examination of the surgical specimen. We aimed to define a transcriptomic signature associated with MVI...

Cite
Beaufrère A, Caruso S, Calderaro J, et al. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. J Hepatol. 2021;76(2):343-352doi: 10.1016/j.jhep.2021.09.034.
Beaufrère, A., Caruso, S., Calderaro, J., Poté, N., Bijot, J. C., Couchy, G., Cauchy, F., Vilgrain, V., Zucman-Rossi, J., & Paradis, V. (2022). Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. Journal of hepatology, 76(2), 343-352. https://doi.org/10.1016/j.jhep.2021.09.034
Beaufrère, Aurélie, et al. "Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies." Journal of hepatology vol. 76,2 (2022): 343-352. doi: https://doi.org/10.1016/j.jhep.2021.09.034
Beaufrère A, Caruso S, Calderaro J, Poté N, Bijot JC, Couchy G, Cauchy F, Vilgrain V, Zucman-Rossi J, Paradis V. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. J Hepatol. 2022 Feb;76(2):343-352. doi: 10.1016/j.jhep.2021.09.034. Epub 2021 Oct 06. PMID: 34624411.
Copy Download .nbib Format: NLM
Gender discrepancy in research activities during radiology residency.

Insights into imaging

Vernuccio F, Arzanauskaite M, Turk S, Torres ET, Choa JMD, Udare AS, Haroun D, Serra MM, Shelmerdine S, Bold B, Bae JS, Romero EE, Vilgrain V.
PMID: 31865450
Insights Imaging. 2019 Dec 21;10(1):125. doi: 10.1186/s13244-019-0792-9.

OBJECTIVE: To investigate the presence of gender disparity in academic involvement during radiology residency and to identify and characterize any gender differences in perceived barriers for conducting research.METHODS: An international call for participation in an online survey was promoted...

Cite
Vernuccio F, Arzanauskaite M, Turk S, et al. Gender discrepancy in research activities during radiology residency. Insights Imaging. 2019;10(1):125doi: 10.1186/s13244-019-0792-9.
Vernuccio, F., Arzanauskaite, M., Turk, S., Torres, E. T., Choa, J. M. D., Udare, A. S., Haroun, D., Serra, M. M., Shelmerdine, S., Bold, B., Bae, J. S., Romero, E. E., & Vilgrain, V. (2019). Gender discrepancy in research activities during radiology residency. Insights into imaging, 10(1), 125. https://doi.org/10.1186/s13244-019-0792-9
Vernuccio, Federica, et al. "Gender discrepancy in research activities during radiology residency." Insights into imaging vol. 10,1 (2019): 125. doi: https://doi.org/10.1186/s13244-019-0792-9
Vernuccio F, Arzanauskaite M, Turk S, Torres ET, Choa JMD, Udare AS, Haroun D, Serra MM, Shelmerdine S, Bold B, Bae JS, Romero EE, Vilgrain V. Gender discrepancy in research activities during radiology residency. Insights Imaging. 2019 Dec 21;10(1):125. doi: 10.1186/s13244-019-0792-9. PMID: 31865450; PMCID: PMC6925606.
Copy Download .nbib Format: NLM
Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma.

JHEP reports : innovation in hepatology

Souhami A, Sartoris R, Rautou PE, Cauchy F, Bouattour M, Durand F, Giannelli V, Gigante E, Castera L, Valla D, Soubrane O, Vilgrain V, Ronot M.
PMID: 32885156
JHEP Rep. 2020 Jul 17;2(5):100147. doi: 10.1016/j.jhepr.2020.100147. eCollection 2020 Oct.

BACKGROUND & AIMS: We compare the performance of liver surface nodularity (LSN) and liver stiffness measurements (LSM) using transient elastography (TE) for the detection of clinically significant portal hypertension (CSPH) in patients with cirrhosis and hepatocellular carcinoma (HCC).METHODS: All...

Cite
Souhami A, Sartoris R, Rautou PE, et al. Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. JHEP Rep. 2020;2(5):100147doi: 10.1016/j.jhepr.2020.100147.
Souhami, A., Sartoris, R., Rautou, P. E., Cauchy, F., Bouattour, M., Durand, F., Giannelli, V., Gigante, E., Castera, L., Valla, D., Soubrane, O., Vilgrain, V., & Ronot, M. (2020). Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. JHEP reports : innovation in hepatology, 2(5), 100147. https://doi.org/10.1016/j.jhepr.2020.100147
Souhami, Alexandra, et al. "Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma." JHEP reports : innovation in hepatology vol. 2,5 (2020): 100147. doi: https://doi.org/10.1016/j.jhepr.2020.100147
Souhami A, Sartoris R, Rautou PE, Cauchy F, Bouattour M, Durand F, Giannelli V, Gigante E, Castera L, Valla D, Soubrane O, Vilgrain V, Ronot M. Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. JHEP Rep. 2020 Jul 17;2(5):100147. doi: 10.1016/j.jhepr.2020.100147. eCollection 2020 Oct. PMID: 32885156; PMCID: PMC7452899.
Copy Download .nbib Format: NLM
Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Paisant A, Lemoine S, Cassinotto C, de Lédinghen V, Ronot M, Irlès-Depé M, Vilgrain V, Le Bail B, Paradis V, Canivet CM, Michalak S, Rousselet MC, Rautou PE, Lebigot J, Hunault G, Crouan A, Aubé C, Boursier J.
PMID: 33340779
Clin Gastroenterol Hepatol. 2020 Dec 16; doi: 10.1016/j.cgh.2020.12.013. Epub 2020 Dec 16.

BACKGROUND & AIMS: Two-dimensional shear wave elastography (2D-SWE) is an accurate method for the non-invasive evaluation of liver fibrosis. We aimed to determine the reliability criteria and the number of necessary reliable measurements for 2D-SWE.METHODS: 788 patients with chronic...

Cite
Paisant A, Lemoine S, Cassinotto C, et al. Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients. Clin Gastroenterol Hepatol. 2020;doi: 10.1016/j.cgh.2020.12.013.
Paisant, A., Lemoine, S., Cassinotto, C., de Lédinghen, V., Ronot, M., Irlès-Depé, M., Vilgrain, V., Le Bail, B., Paradis, V., Canivet, C. M., Michalak, S., Rousselet, M. C., Rautou, P. E., Lebigot, J., Hunault, G., Crouan, A., Aubé, C., & Boursier, J. (2020). Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, . https://doi.org/10.1016/j.cgh.2020.12.013
Paisant, Anita, et al. "Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients." Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. (2020). doi: https://doi.org/10.1016/j.cgh.2020.12.013
Paisant A, Lemoine S, Cassinotto C, de Lédinghen V, Ronot M, Irlès-Depé M, Vilgrain V, Le Bail B, Paradis V, Canivet CM, Michalak S, Rousselet MC, Rautou PE, Lebigot J, Hunault G, Crouan A, Aubé C, Boursier J. Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients. Clin Gastroenterol Hepatol. 2020 Dec 16; doi: 10.1016/j.cgh.2020.12.013. Epub 2020 Dec 16. PMID: 33340779.
Copy Download .nbib Format: NLM
Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies.

Journal of hepatology

Beaufrère A, Caruso S, Calderaro J, Poté N, Bijot JC, Couchy G, Cauchy F, Vilgrain V, Zucman-Rossi J, Paradis V.
PMID: 34624411
J Hepatol. 2021 Oct 06; doi: 10.1016/j.jhep.2021.09.034. Epub 2021 Oct 06.

BACKGROUND & AIMS: Microvascular invasion (MVI), a major risk factor for tumor recurrence after surgery in hepatocellular carcinoma (HCC), is only detectable by microscopic examination of the surgical specimen. We aimed to define a transcriptomic signature associated with MVI...

Cite
Beaufrère A, Caruso S, Calderaro J, et al. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. J Hepatol. 2021;doi: 10.1016/j.jhep.2021.09.034.
Beaufrère, A., Caruso, S., Calderaro, J., Poté, N., Bijot, J. C., Couchy, G., Cauchy, F., Vilgrain, V., Zucman-Rossi, J., & Paradis, V. (2021). Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. Journal of hepatology, . https://doi.org/10.1016/j.jhep.2021.09.034
Beaufrère, Aurélie, et al. "Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies." Journal of hepatology vol. (2021). doi: https://doi.org/10.1016/j.jhep.2021.09.034
Beaufrère A, Caruso S, Calderaro J, Poté N, Bijot JC, Couchy G, Cauchy F, Vilgrain V, Zucman-Rossi J, Paradis V. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. J Hepatol. 2021 Oct 06; doi: 10.1016/j.jhep.2021.09.034. Epub 2021 Oct 06. PMID: 34624411.
Copy Download .nbib Format: NLM
Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease.

Journal of hepatology

De Broucker C, Plessier A, Ollivier-Hourmand I, Dharancy S, Bureau C, Cervoni JP, Sogni P, Goria O, Corcos O, Sartoris R, Ronot M, Vilgrain V, de Raucourt E, Zekrini K, Davy H, Durand F, Payancé A, Fidouh-Houhou N, Yazdanpanah Y, Valla D, Rautou PE.
PMID: 34563580
J Hepatol. 2021 Sep 23; doi: 10.1016/j.jhep.2021.09.011. Epub 2021 Sep 23.

BACKGROUND & AIMS: Recent non-malignant non-cirrhotic portal venous system thrombosis (PVT) is a rare condition. Among risk factors for PVT, cytomegalovirus (CMV) disease is usually listed based on a small number of reported cases. The aim of this study...

Cite
De Broucker C, Plessier A, Ollivier-Hourmand I, et al. Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease. J Hepatol. 2021;doi: 10.1016/j.jhep.2021.09.011.
De Broucker, C., Plessier, A., Ollivier-Hourmand, I., Dharancy, S., Bureau, C., Cervoni, J. P., Sogni, P., Goria, O., Corcos, O., Sartoris, R., Ronot, M., Vilgrain, V., de Raucourt, E., Zekrini, K., Davy, H., Durand, F., Payancé, A., Fidouh-Houhou, N., Yazdanpanah, Y., Valla, D., & Rautou, P. E. (2021). Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease. Journal of hepatology, . https://doi.org/10.1016/j.jhep.2021.09.011
De Broucker, Chloé, et al. "Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease." Journal of hepatology vol. (2021). doi: https://doi.org/10.1016/j.jhep.2021.09.011
De Broucker C, Plessier A, Ollivier-Hourmand I, Dharancy S, Bureau C, Cervoni JP, Sogni P, Goria O, Corcos O, Sartoris R, Ronot M, Vilgrain V, de Raucourt E, Zekrini K, Davy H, Durand F, Payancé A, Fidouh-Houhou N, Yazdanpanah Y, Valla D, Rautou PE. Multicenter study on recent portal venous system thrombosis associated with cytomegalovirus disease. J Hepatol. 2021 Sep 23; doi: 10.1016/j.jhep.2021.09.011. Epub 2021 Sep 23. PMID: 34563580.
Copy Download .nbib Format: NLM
Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors.

European radiology

Benoit C, Rodrigues A, Calderaro J, Charpy C, Simonin S, Deybach JC, Gouya L, Puy H, Schmitt C, Farcy R, Vilgrain V, Paradis V, Pote N, Lafdil F, Mule S, Itti E, Luciani A.
PMID: 34694452
Eur Radiol. 2021 Oct 25; doi: 10.1007/s00330-021-08307-9. Epub 2021 Oct 25.

OBJECTIVES: To assess the performance of 405 nm-induced autofluorescence for the characterization of primary liver nodules on ex vivo resected specimens.MATERIALS AND METHODS: Forty resected liver specimens bearing 53 primary liver nodules were included in this IRB-approved prospective study....

Cite
Benoit C, Rodrigues A, Calderaro J, et al. Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors. Eur Radiol. 2021;doi: 10.1007/s00330-021-08307-9.
Benoit, C., Rodrigues, A., Calderaro, J., Charpy, C., Simonin, S., Deybach, J. C., Gouya, L., Puy, H., Schmitt, C., Farcy, R., Vilgrain, V., Paradis, V., Pote, N., Lafdil, F., Mule, S., Itti, E., & Luciani, A. (2021). Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors. European radiology, . https://doi.org/10.1007/s00330-021-08307-9
Benoit, Charlotte, et al. "Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors." European radiology vol. (2021). doi: https://doi.org/10.1007/s00330-021-08307-9
Benoit C, Rodrigues A, Calderaro J, Charpy C, Simonin S, Deybach JC, Gouya L, Puy H, Schmitt C, Farcy R, Vilgrain V, Paradis V, Pote N, Lafdil F, Mule S, Itti E, Luciani A. Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors. Eur Radiol. 2021 Oct 25; doi: 10.1007/s00330-021-08307-9. Epub 2021 Oct 25. PMID: 34694452.
Copy Download .nbib Format: NLM
Reply: Soluble VE-cadherin: not just a marker of endothelial permeability.

The European respiratory journal

Harki O, Faury G, Vilgrain I, Pépin JL, Briançon-Marjollet A.
PMID: 34711535
Eur Respir J. 2021 Dec 16;58(6). doi: 10.1183/13993003.02629-2021. Print 2021 Dec.

No abstract available.

Cite
Harki O, Faury G, Vilgrain I, et al. Reply: Soluble VE-cadherin: not just a marker of endothelial permeability. Eur Respir J. 2021;58(6)doi: 10.1183/13993003.02629-2021.
Harki, O., Faury, G., Vilgrain, I., Pépin, J. L., & Briançon-Marjollet, A. (2021). Reply: Soluble VE-cadherin: not just a marker of endothelial permeability. The European respiratory journal, 58(6), . https://doi.org/10.1183/13993003.02629-2021
Harki, Olfa, et al. "Reply: Soluble VE-cadherin: not just a marker of endothelial permeability." The European respiratory journal vol. 58,6 (2021). doi: https://doi.org/10.1183/13993003.02629-2021
Harki O, Faury G, Vilgrain I, Pépin JL, Briançon-Marjollet A. Reply: Soluble VE-cadherin: not just a marker of endothelial permeability. Eur Respir J. 2021 Dec 16;58(6). doi: 10.1183/13993003.02629-2021. Print 2021 Dec. PMID: 34711535.
Copy Download .nbib Format: NLM
Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?.

Endocrine connections

Zappa M, Hentic O, Vullierme MP, Lagadec M, Ronot M, Ruszniewski P, Vilgrain V.
PMID: 28069898
Endocr Connect. 2017 Jan;6(1):33-38. doi: 10.1530/EC-16-0092. Epub 2017 Jan 09.

BACKGROUND: Visual semi-quantitative assessment of liver tumour burden for neuroendocrine tumour liver metastases is often used in patient management and outcome. However, published data on the reproducibility of these evaluations are lacking.OBJECTIVE: The aim of this study was to...

Cite
Zappa M, Hentic O, Vullierme MP, et al. Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?. Endocr Connect. 2017;6(1):33-38doi: 10.1530/EC-16-0092.
Zappa, M., Hentic, O., Vullierme, M. P., Lagadec, M., Ronot, M., Ruszniewski, P., & Vilgrain, V. (2017). Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?. Endocrine connections, 6(1), 33-38. https://doi.org/10.1530/EC-16-0092
Zappa, Magaly, et al. "Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?." Endocrine connections vol. 6,1 (2017): 33-38. doi: https://doi.org/10.1530/EC-16-0092
Zappa M, Hentic O, Vullierme MP, Lagadec M, Ronot M, Ruszniewski P, Vilgrain V. Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?. Endocr Connect. 2017 Jan;6(1):33-38. doi: 10.1530/EC-16-0092. Epub 2017 Jan 09. PMID: 28069898; PMCID: PMC5302166.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 69 entries